Double-blind, Randomized, Placebo-controlled Study for the Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of GLPG0974 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 08 Feb 2016
At a glance
- Drugs GLPG 0974 (Primary)
- Indications Inflammatory bowel diseases
- Focus Adverse reactions; Biomarker
- 08 Feb 2016 Results of this and other trial (see profile 213949) published in the British Journal of Clinical Pharmacology
- 16 Oct 2013 Results will be presented at the United European Gastroenterology Week, according to a media release.
- 27 Mar 2013 Results have been published in a Galapagos NV media release.